Cargando…
A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading cause of cancer related death in men. The early diagnosis and treatment of PCa are still challenging due to the lack of efficient tumor targeting agents in traditional managements. Prostate specific membrane antig...
Autores principales: | Han, Donghui, Wu, Jieheng, Han, Yueheng, Wei, Ming, Han, Sen, Lin, Ruihe, Sun, Ziyong, Yang, Fa, Jiao, Dian, Xie, Pin, Zhang, Lingling, Yang, An-Gang, Zhao, Aizhi, Wen, Weihong, Qin, Weijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312325/ https://www.ncbi.nlm.nih.gov/pubmed/27448970 http://dx.doi.org/10.18632/oncotarget.10697 |
Ejemplares similares
-
Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
por: Zhao, Aizhi, et al.
Publicado: (2007) -
In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe
por: Mazzocco, Claire, et al.
Publicado: (2016) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012) -
Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)